Medicare Enrolled
Dr. Raymonda Rastegar, M.D.
Cardiovascular Disease · New York, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rastegar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rastegar?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rastegar
Dr. Raymonda Rastegar is a cardiovascular disease specialist in New York, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rastegar performed 11,913 Medicare services across 6,486 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rastegar received a total of $222,847 from 44 pharmaceutical and/or device companies across 969 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rastegar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 2% volume in NY
$222,847 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,913
Medicare services
Top 2% in NY for cardiovascular disease
6,486
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~627 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,678 | $12 | $150 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,583 | $106 | $350 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
1,382 | $53 | $74 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
996 | $75 | $250 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
847 | $156 | $1,500 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
666 | $34 | $350 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
504 | $8 | $150 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
492 | $92 | $400 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
485 | $42 | $250 |
| Heart muscle strain imaging | 425 | $33 | $80 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
385 | $43 | $350 |
| Injection, dipyridamole, per 10 mg | 359 | $3 | $400 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
290 | $54 | $550 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
246 | $385 | $3,000 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
165 | $139 | $350 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
140 | $19 | $100 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
139 | $11 | $50 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
136 | $143 | $600 |
| Aminophylline injection, up to 250 mg Administration of aminophylline medication via injection for a dose of up to 250 mg. |
128 | $7 | $50 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
126 | $240 | $475 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
110 | $165 | $1,100 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
91 | $64 | $450 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
82 | $73 | $250 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
80 | $22 | $200 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
63 | $44 | $150 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
61 | $107 | $350 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
44 | $65 | $350 |
| New patient office visit, complex (60-74 min) | 43 | $175 | $750 |
| Quadrivalent influenza vaccine, cell culture-derived A flu shot that protects against four strains of the influenza virus. It is produced using cell culture technology rather than traditional egg-based methods. |
28 | $32 | $150 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
28 | $35 | $150 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
26 | $140 | $500 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
25 | $48 | $150 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
20 | $66 | $700 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
14 | $57 | $450 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
13 | $22 | $300 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
13 | $766 | $1,525 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.1% high complexity
17.4% medium
75.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$222,847
Total received (2018-2024)
Avg $31,835/year across 7 years
Top 2% in NY for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
969
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$199,300 (89.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,180 (9.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,367 (1.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$20,055
2023
$60,655
2022
$102,936
2021
$4,147
2020
$3,296
2019
$21,992
2018
$9,766
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$17,840
AstraZeneca Pharmaceuticals LP
$274
Esperion Therapeutics, Inc.
$196
Lilly USA, LLC
$192
Merck Sharp & Dohme LLC
$175
Amgen Inc.
$173
Boehringer Ingelheim Pharmaceuticals, Inc.
$172
Lexicon Pharmaceuticals, Inc.
$168
Actelion Pharmaceuticals US, Inc.
$160
Janssen Pharmaceuticals, Inc
$148
Bayer Healthcare Pharmaceuticals Inc.
$112
Novartis Pharmaceuticals Corporation
$101
GlaxoSmithKline, LLC.
$68
Kowa Pharmaceuticals America, Inc.
$50
SANOFI-AVENTIS U.S. LLC
$46
E.R. Squibb & Sons, L.L.C.
$35
Boston Scientific Corporation
$29
AGEPHA Pharma FZ LLC
$28
PFIZER INC.
$24
Alnylam Pharmaceuticals Inc.
$24
ANI Pharmaceuticals, Inc.
$22
Currax Pharmaceuticals LLC
$18
Top 3 companies account for 91.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$173,788
Amarin Pharma Inc.
$18,879
SANOFI-AVENTIS U.S. LLC
$7,338
Lexicon Pharmaceuticals, Inc.
$3,535
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,407
AstraZeneca Pharmaceuticals LP
$1,893
PFIZER INC.
$1,771
Janssen Pharmaceuticals, Inc
$1,450
Amgen Inc.
$1,303
Esperion Therapeutics, Inc.
$937
Novartis Pharmaceuticals Corporation
$848
Actelion Pharmaceuticals US, Inc.
$838
Lilly USA, LLC
$833
Kowa Pharmaceuticals America, Inc.
$826
BIOTRONIK INC.
$810
E.R. Squibb & Sons, L.L.C.
$674
Abbott Laboratories
$563
Lundbeck LLC
$545
Boston Scientific Corporation
$502
Merck Sharp & Dohme LLC
$367
Medtronic Vascular, Inc.
$356
Medtronic, Inc.
$314
ARBOR PHARMACEUTICALS, INC.
$234
Regeneron Healthcare Solutions, Inc.
$227
G Medical Diagnostic Services, Inc.
$214
Bayer Healthcare Pharmaceuticals Inc.
$193
Alnylam Pharmaceuticals Inc.
$190
GlaxoSmithKline, LLC.
$181
Akcea Therapeutics, Inc.
$175
Relypsa, Inc.
$122
Bayer HealthCare Pharmaceuticals Inc.
$110
Arbor Pharmaceuticals, Inc.
$75
Vifor Pharma, Inc.
$63
Merck Sharp & Dohme Corporation
$59
BOSTON SCIENTIFIC CORPORATION
$46
AGEPHA Pharma FZ LLC
$28
Azurity Pharmaceuticals, Inc.
$27
Daiichi Sankyo Inc.
$24
ANI Pharmaceuticals, Inc.
$22
AbbVie Inc.
$21
Currax Pharmaceuticals LLC
$18
Philips Electronics North America Corporation
$17
Teva Pharmaceuticals USA, Inc.
$16
ARALEZ PHARMACEUTICALS US INC.
$11
Top 3 companies account for 89.7% of all-time payments
Associated products mentioned in payments ›
(5050) Ext Holter · ANORO ELLIPTA · AUSTEDO · AVALUS · Acticor · Adempas · BIOMONITOR · BRILINTA · BioMonitor · BioMonitor 2 · CAMZYOS · CHANTIX · CONTRAVE · Cardiac Monitoring Suite · CardioMEMS HF System · Cobalt · Corlanor · ELIQUIS · ENTRESTO · Edarbi · Edarbyclor · Ensite Cardiac Mapping System · FARXIGA · INJECTAFER · INVOKANA · Inpefa · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINQ II · LIVALO · LODOCO · LUX-Dx Insertable Cardiac Monitor · Livalo · MITRACLIP · MOUNJARO · MULTAQ · Mitra Clip system · MitraClip System · NEXLETOL · NEXLIZET · NORTHERA · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PURIFIED CORTROPHIN GEL · Prolia · REVEAL LINQ · RYBELSUS · Repatha · Reveal LINQ · Rybelsus · SYNTHROID · Solia · TEGSEDI · TRELEGY ELLIPTA · TRULICITY · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · Veltassa · Verquvo · WAINUA · WATCHMAN · WATCHMAN FLX · XARELTO · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (89%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for cardiovascular disease in NY.
Geographic Context
Cardiologists within 10 mi
1,842
Per 100K population
113.2
County median income
$104,553
Nearest hospital
BELLEVUE HOSPITAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rastegar is a clinical cardiology specialist, with above-average Medicare volume (top 2% in NY), with speaking/promotional industry engagement in the top 2% of NY peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rastegar experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Rastegar performed 1,678 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rastegar receive payments from pharmaceutical companies?
Yes. Dr. Rastegar received a total of $222,847 from 44 companies across 969 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rastegar's costs compare to other cardiologists in New York?
Dr. Rastegar's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rastegar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in New York
Browse cardiologists in New York ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NY
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NY
Which NY cardiologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Amarin Pharma Inc. Payments to Doctors
See all physicians who received payments from Amarin Pharma Inc.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology